Investors still waiting for Pfizer’s ( PFE ) stock to rebound may need a little more patience, but there are reasons to stay optimistic. The share price hasn’t moved much since my last coverage , but those who valueHi, I'm Yiannis. Spotting winners before they break out is what I do best.Experience: Previously worked at Deloitte and KPMG in external/internal auditing and consulting. Education: Chartered Certified Accountant, Fellow Member of ACCA Global, with BSc and MSc degrees from U.K. business schools. ...